Flaw in Alzheimer's drug trial test, research suggests
New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose. View full story